MetaADEDB 2.0 @ LMMD
Mycophenolic Acid
(RTGDFNSFWBGLEC-SYZQJQIISA-N)
Structure
SMILES
COc1c(C/C=C(/CCC(=O)OCCN2CCOCC2)\C)c(O)c2c(c1C)COC2=O
Type(s)
Approved; Investigational
Molecular Formula:
C23H31NO7
Molecular Weight:
433.495
Log P:
2.4619
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
1
TPSA:
94.53
CAS Number(s):
115007-34-6; 128794-94-5
Synonym(s)
1.
Mycophenolic Acid
2.
Cellcept
3.
Mycophenolate Mofetil
4.
Mycophenolate Mofetil Hydrochloride
5.
Mycophenolate Sodium
6.
Mycophenolic Acid Morpholinoethyl Ester
7.
Myfortic
8.
RS 61443
9.
RS-61443
10.
Sodium Mycophenolate
11.
Mofetil Hydrochloride, Mycophenolate
12.
Mofetil, Mycophenolate
13.
Mycophenolate, Sodium
14.
RS61443
External Link(s)
MeSHD009173
PubChem Compound5281078
BindingDB50248299
ChEBI93612
8764
CHEMBLCHEMBL1456
DrugBankDB00688
DrugCentral1859
IUPHAR/BPS Guide to PHARMACOLOGY6831
KEGGcpd:C07908
dr:D00752
Therapeutic Target DatabaseD0MS5I
D04FBR
ZINC21297660
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Intentional product use issueFAERS: 145US FAERS
2MalaiseFAERS: 123US FAERS
3Drug dose omissionFAERS: 111US FAERS
4NauseaFAERS: 100
Canada Vigilance: 1
Canada Vigilance
US FAERS
5No adverse eventFAERS: 96US FAERS
6PneumoniaFAERS: 96US FAERS
7Drug ineffectiveFAERS: 94
Canada Vigilance: 9
Canada Vigilance
US FAERS
8Cerebrovascular accidentFAERS: 92
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Product use in unapproved indicationFAERS: 83
Canada Vigilance: 2
Canada Vigilance
US FAERS
10VomitingFAERS: 83US FAERS
11InfectionFAERS: 72
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
12ColitisFAERS: 66
Canada Vigilance: 1
Canada Vigilance
US FAERS
13HeadacheFAERS: 65US FAERS
14FatigueFAERS: 62
Canada Vigilance: 2
Canada Vigilance
US FAERS
15HypercreatinaemiaFAERS: 57US FAERS
16Myocardial InfarctionFAERS: 56US FAERS
17Abdominal PainFAERS: 52US FAERS
18Blood creatinine increasedFAERS: 51OFFSIDES
US FAERS
19Respiratory FailureFAERS: 47OFFSIDES
US FAERS
20Disease ProgressionFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Therapy cessationFAERS: 44US FAERS
22Abdominal discomfortFAERS: 41US FAERS
23AstheniaFAERS: 39US FAERS
24Medication ErrorFAERS: 38US FAERS
25Weight decreasedFAERS: 38US FAERS
26DizzinessFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
27SepsisFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Urinary tract infectionFAERS: 36US FAERS
29Disease recurrenceFAERS: 33
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
30ApoptosisFAERS: 32US FAERS
31Product substitution issueFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
32AlopeciaFAERS: 31OFFSIDES
US FAERS
33Cardiac ArrestFAERS: 30US FAERS
34Incorrect dose administeredFAERS: 30US FAERS
35Maternal exposure during pregnancyFAERS: 30
Canada Vigilance: 4
Canada Vigilance
US FAERS
36NeutropeniaFAERS: 30US FAERS
37Peripheral swellingFAERS: 29US FAERS
38DehydrationFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
39LeukopeniaFAERS: 27US FAERS
40PainFAERS: 27OFFSIDES
US FAERS
41ProteinuriaFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
42TremorFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
43PruritusFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
44treatment failureFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
45ArthralgiaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
46Back PainFAERS: 24US FAERS
47PregnancyFAERS: 24US FAERS
48Wrong technique in product usage processFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
49HepatotoxicityFAERS: 23US FAERS
50ThrombocytopeniaFAERS: 23US FAERS
51White blood cell count decreasedFAERS: 23US FAERS
52BlindnessFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
53Drug ineffective for unapproved indicationFAERS: 22US FAERS
54Nephrotic SyndromeFAERS: 22US FAERS
55Product quality issueFAERS: 21US FAERS
56AnxietyFAERS: 20OFFSIDES
US FAERS
57GlomerulonephritisFAERS: 20US FAERS
58Septic ShockFAERS: 19US FAERS
59Suicide attemptFAERS: 19US FAERS
60ThrombosisFAERS: 19US FAERS
61DyspepsiaFAERS: 18US FAERS
62General physical health deteriorationFAERS: 18OFFSIDES
US FAERS
63Viral upper respiratory tract infectionFAERS: 18US FAERS
64BronchiectasisFAERS: 17US FAERS
65InfluenzaFAERS: 17US FAERS
66Lupus NephritisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
67MyalgiaFAERS: 17US FAERS
68Myasthenia GravisFAERS: 17US FAERS
69AgranulocytosisFAERS: 16US FAERS
70AmnesiaFAERS: 16US FAERS
71Apoptotic colonopathyFAERS: 16US FAERS
72DeafnessFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
73OverdoseFAERS: 16US FAERS
74PancreatitisFAERS: 16US FAERS
75Product dose omissionFAERS: 16US FAERS
76AbasiaFAERS: 15OFFSIDES
US FAERS
77AscitesFAERS: 15US FAERS
78Chest PainFAERS: 15US FAERS
79ConstipationFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Feeling abnormalFAERS: 15US FAERS
81Memory impairmentFAERS: 15US FAERS
82Remission not achievedFAERS: 15US FAERS
83HypersensitivityFAERS: 14US FAERS
84HypotensionFAERS: 14US FAERS
85Liver transplant rejectionFAERS: 14OFFSIDES
US FAERS
86Pulmonary EmbolismFAERS: 14US FAERS
87SinusitisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Therapy non-responderFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
89CellulitisFAERS: 13US FAERS
90Diabetes MellitusFAERS: 13US FAERS
91Posterior reversible encephalopathy syndromeFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
92Visual ImpairmentFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
93Drug exposure during pregnancyFAERS: 12US FAERS
94Exposure via fatherFAERS: 12US FAERS
95Gastrointestinal toxicityFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Intestinal ObstructionFAERS: 12US FAERS
97SwellingFAERS: 12US FAERS
98Toxicity to various agentsFAERS: 12US FAERS
99Acute kidney injuryFAERS: 11US FAERS
100Drug administration errorFAERS: 11US FAERS
101Product use issueFAERS: 11US FAERS
102Skin UlcerFAERS: 11US FAERS
103UrticariaFAERS: 11US FAERS
104BronchitisFAERS: 10US FAERS
105ErythemaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
106TachycardiaFAERS: 10US FAERS
107Therapy changeFAERS: 10US FAERS
108Transaminases increasedFAERS: 10US FAERS
109Blood glucose increasedFAERS: 9US FAERS
110DysgeusiaFAERS: 9US FAERS
111EpilepsyFAERS: 9OFFSIDES
US FAERS
112FlatulenceFAERS: 9US FAERS
113Hepatitis CFAERS: 9OFFSIDES
US FAERS
114Product dispensing errorFAERS: 9US FAERS
115Unevaluable eventFAERS: 9US FAERS
116Accidental exposure to productFAERS: 8US FAERS
117Cerebral InfarctionFAERS: 8US FAERS
118ChillsFAERS: 8US FAERS
119ChokingFAERS: 8US FAERS
120Intercepted medication errorFAERS: 8US FAERS
121Joint swellingFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Large intestine perforationFAERS: 8US FAERS
123Multiple SclerosisFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
124NephrosclerosisFAERS: 8US FAERS
125Optic NeuritisFAERS: 8US FAERS
126Oropharyngeal painFAERS: 8OFFSIDES
US FAERS
127VasculitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
128jaundiceFAERS: 8US FAERS
129nervous system disorderFAERS: 8US FAERS
130Acute myocardial infarctionFAERS: 7US FAERS
131AsthmaFAERS: 7US FAERS
132Chest discomfortFAERS: 7US FAERS
133CholelithiasisFAERS: 7US FAERS
134DementiaFAERS: 7US FAERS
135Expired product administeredFAERS: 7US FAERS
136Failure to ThriveFAERS: 7US FAERS
137Hepatic EncephalopathyFAERS: 7US FAERS
138HepatitisFAERS: 7US FAERS
139ImmunosuppressionFAERS: 7US FAERS
140LymphomaFAERS: 7US FAERS
141MeningitisFAERS: 7US FAERS
142Night sweatsFAERS: 7US FAERS
143PancytopeniaFAERS: 7US FAERS
144PeritonitisFAERS: 7US FAERS
145Pulmonary FibrosisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Skin lesionFAERS: 7OFFSIDES
US FAERS
147SomnolenceFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
148Squamous cell carcinomaFAERS: 7US FAERS
149Status EpilepticusFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
150Accidental overdoseFAERS: 6US FAERS
151Acute respiratory failureFAERS: 6US FAERS
152Adverse eventFAERS: 6US FAERS
153AngioedemaFAERS: 6US FAERS
154Ankle FractureFAERS: 6US FAERS
155Atrial FibrillationFAERS: 6US FAERS
156Bone painFAERS: 6OFFSIDES
US FAERS
157C3 glomerulopathyFAERS: 6US FAERS
158Circumstance or information capable of leading to medication errorFAERS: 6US FAERS
159Completed SuicideFAERS: 6US FAERS
160CytopeniaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
161Drug dispensing errorFAERS: 6US FAERS
162Dry skinFAERS: 6OFFSIDES
US FAERS
163EnteritisFAERS: 6US FAERS
164Full blood count decreasedFAERS: 6US FAERS
165GoutFAERS: 6OFFSIDES
US FAERS
166LymphopeniaFAERS: 6US FAERS
167MalabsorptionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
168Mental status changesFAERS: 6US FAERS
169NasopharyngitisFAERS: 6US FAERS
170Peripheral arterial occlusive diseaseFAERS: 6US FAERS
171Product preparation errorFAERS: 6US FAERS
172Respiratory arrestFAERS: 6US FAERS
173SclerodermaFAERS: 6US FAERS
174Skin hypertrophyFAERS: 6OFFSIDES
US FAERS
175StressFAERS: 6US FAERS
176AcneFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
177BK virus infectionFAERS: 5US FAERS
178Biliary sepsisFAERS: 5US FAERS
179Blood urea increasedFAERS: 5US FAERS
180CholangitisFAERS: 5US FAERS
181CholecystitisFAERS: 5US FAERS
182Cleft PalateFAERS: 5US FAERS
183CystitisFAERS: 5US FAERS
184Drug prescribing errorFAERS: 5OFFSIDES
US FAERS
185DysarthriaFAERS: 5US FAERS
186DysuriaFAERS: 5US FAERS
187Emotional distressFAERS: 5OFFSIDES
US FAERS
188Exposure via skin contactFAERS: 5US FAERS
189Extra dose administeredFAERS: 5US FAERS
190GangreneFAERS: 5US FAERS
191GastritisFAERS: 5US FAERS
192GlaucomaFAERS: 5OFFSIDES
US FAERS
193HerniaFAERS: 5US FAERS
194HyperkeratosisFAERS: 5OFFSIDES
US FAERS
195Insurance issueFAERS: 5US FAERS
196LaryngitisFAERS: 5US FAERS
197LethargyFAERS: 5US FAERS
198Lower respiratory tract infectionFAERS: 5US FAERS
199Macular degenerationFAERS: 5US FAERS
200Metastatic NeoplasmFAERS: 5US FAERS
201MyopathyFAERS: 5US FAERS
202NecrosisFAERS: 5US FAERS
203NephrolithiasisFAERS: 5US FAERS
204PalpitationsFAERS: 5US FAERS
205PneumonitisFAERS: 5US FAERS
206Pregnancy of partnerFAERS: 5US FAERS
207Productive CoughFAERS: 5US FAERS
208Renal tubular necrosisFAERS: 5OFFSIDES
US FAERS
209Respiratory distressFAERS: 5US FAERS
210Activities of daily living impairedFAERS: 4US FAERS
211ArthritisFAERS: 4US FAERS
212Autoimmune hepatitisFAERS: 4OFFSIDES
US FAERS
213Basal cell carcinomaFAERS: 4US FAERS
214BedriddenFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
215Blood creatine phosphokinase increasedFAERS: 4US FAERS
216BradycardiaFAERS: 4US FAERS
217CandidiasisFAERS: 4US FAERS
218CataractFAERS: 4OFFSIDES
US FAERS
219Cerebral disorderFAERS: 4US FAERS
220Colonoscopy abnormalFAERS: 4US FAERS
221Coronary Artery DiseaseFAERS: 4US FAERS
222Deep Vein ThrombosisFAERS: 4US FAERS
223Double Outlet Right VentricleFAERS: 4US FAERS
224EczemaFAERS: 4US FAERS
225EndocarditisFAERS: 4OFFSIDES
US FAERS
226Febrile NeutropeniaFAERS: 4US FAERS
227Flank PainFAERS: 4US FAERS
228GastroenteritisFAERS: 4OFFSIDES
US FAERS
229HyperparathyroidismFAERS: 4US FAERS
230Hypertensive crisisFAERS: 4US FAERS
231HypophagiaFAERS: 4US FAERS
232Immunosuppressant drug level decreasedFAERS: 4
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
233Inappropriate schedule of drug administrationFAERS: 4US FAERS
234Incorrect product storageFAERS: 4US FAERS
235InflammationFAERS: 4US FAERS
236Injection site extravasationFAERS: 4US FAERS
237Intestinal PerforationFAERS: 4US FAERS
238LeukocytosisFAERS: 4US FAERS
239LeukoencephalopathyFAERS: 4US FAERS
240Lip swellingFAERS: 4US FAERS
241Lung transplant rejectionFAERS: 4US FAERS
242Mental impairmentFAERS: 4US FAERS
243Mood swingsFAERS: 4US FAERS
244Pancreatic carcinomaFAERS: 4US FAERS
245Patent ductus arteriosusFAERS: 4US FAERS
246PemphigusFAERS: 4US FAERS
247Pericardial effusionFAERS: 4OFFSIDES
US FAERS
248PericarditisFAERS: 4OFFSIDES
US FAERS
249Polymorphonuclear chromatin clumpingFAERS: 4US FAERS
250Protein urine presentFAERS: 4US FAERS
251Rheumatoid ArthritisFAERS: 4US FAERS
252SyncopeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
253Therapy partial responderFAERS: 4US FAERS
254Throat cancerFAERS: 4US FAERS
255Throat irritationFAERS: 4US FAERS
256VertigoFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
257Wrong patient received medicationFAERS: 4US FAERS
258AbscessFAERS: 3US FAERS
259Acoustic neuritisFAERS: 3US FAERS
260Alanine Aminotransferase IncreasedFAERS: 3OFFSIDES
US FAERS
261AneurysmFAERS: 3US FAERS
262Antinuclear antibody increasedFAERS: 3US FAERS
263ArthropathyFAERS: 3US FAERS
264Back disorderFAERS: 3US FAERS
265Bacterial sepsisFAERS: 3OFFSIDES
US FAERS
266Blood albumin decreasedFAERS: 3US FAERS
267Blood count abnormalFAERS: 3US FAERS
268Blood glucose abnormalFAERS: 3US FAERS
269Blood glucose decreasedFAERS: 3US FAERS
270Blood potassium increasedFAERS: 3OFFSIDES
US FAERS
271Bone marrow depressionFAERS: 3US FAERS
272Bronchopulmonary AspergillosisFAERS: 3US FAERS
273Burning sensationFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
274CalcinosisFAERS: 3US FAERS
275Central nervous system lesionFAERS: 3US FAERS
276Cerebral ThrombosisFAERS: 3US FAERS
277Clostridium difficile infectionFAERS: 3US FAERS
278Complications of maternal exposure to therapeutic drugsFAERS: 3US FAERS
279Complications of transplant surgeryFAERS: 3US FAERS
280CryingFAERS: 3US FAERS
281CystFAERS: 3US FAERS
282Cytomegalovirus gastrointestinal infectionFAERS: 3US FAERS
283Cytomegalovirus test positiveFAERS: 3OFFSIDES
US FAERS
284DeformityFAERS: 3US FAERS
285Disseminated Intravascular CoagulationFAERS: 3US FAERS
286DiverticulitisFAERS: 3US FAERS
287Drug effect incompleteFAERS: 3US FAERS
288Drug level decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
289DysphoniaFAERS: 3US FAERS
290EcchymosisFAERS: 3US FAERS
291Economic problemFAERS: 3US FAERS
292EncephalitisFAERS: 3US FAERS
293EpistaxisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
294Epstein-Barr virus associated lymphoproliferative disorderFAERS: 3OFFSIDES
US FAERS
295Erectile dysfunctionFAERS: 3US FAERS
296Exposure to chemical pollutionFAERS: 3US FAERS
297ExtravasationFAERS: 3US FAERS
298Eye irritationFAERS: 3US FAERS
299FlushingFAERS: 3US FAERS
300FractureFAERS: 3US FAERS
301Frontotemporal dementiaFAERS: 3US FAERS
302GastrectomyFAERS: 3US FAERS
303Gastric ulcerFAERS: 3US FAERS
304Gastrointestinal infectionFAERS: 3US FAERS
305Graft versus host disease in gastrointestinal tractFAERS: 3US FAERS
306Granulomatosis with polyangiitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
307Hepatic necrosisFAERS: 3US FAERS
308Histiocytosis haematophagicFAERS: 3OFFSIDES
US FAERS
309Human polyomavirus infectionFAERS: 3US FAERS
310HydrocephalusFAERS: 3US FAERS
311HyperthyroidismFAERS: 3US FAERS
312Idiopathic Pulmonary FibrosisFAERS: 3US FAERS
313IleusFAERS: 3US FAERS
314Infective glossitisFAERS: 3US FAERS
315InfertilityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
316Intercepted product storage errorFAERS: 3US FAERS
317Intestinal villi atrophyFAERS: 3US FAERS
318Intracranial AneurysmFAERS: 3US FAERS
319LacerationFAERS: 3US FAERS
320Limb discomfortFAERS: 3US FAERS
321Lymphocyte count decreasedFAERS: 3US FAERS
322MalnutritionFAERS: 3US FAERS
323Manufacturing product shipping issueFAERS: 3US FAERS
324Maternal exposure timing unspecifiedFAERS: 3US FAERS
325Medication residue presentFAERS: 3US FAERS
326MyocarditisFAERS: 3US FAERS
327Nerve injuryFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
328NeuritisFAERS: 3US FAERS
329Neutrophil count decreasedFAERS: 3US FAERS
330Neutrophil morphology abnormalFAERS: 3US FAERS
331Paternal exposure during pregnancyFAERS: 3US FAERS
332PleurisyFAERS: 3US FAERS
333Pneumocystis jiroveci pneumoniaFAERS: 3US FAERS
334PolydactylyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
335Poor quality drug administeredFAERS: 3US FAERS
336Product administration errorFAERS: 3US FAERS
337Product contamination physicalFAERS: 3US FAERS
338Product physical issueFAERS: 3US FAERS
339Product taste abnormalFAERS: 3US FAERS
340Pulmonary Valve StenosisFAERS: 3US FAERS
341Pulmonary congestionFAERS: 3US FAERS
342Pulmonary function test decreasedFAERS: 3US FAERS
343RadiculopathyFAERS: 3US FAERS
344Rash erythematousFAERS: 3US FAERS
345Renal painFAERS: 3US FAERS
346RhabdomyolysisFAERS: 3OFFSIDES
US FAERS
347RhinitisFAERS: 3US FAERS
348ShockFAERS: 3US FAERS
349Skin PapillomaFAERS: 3US FAERS
350SomnambulismFAERS: 3US FAERS
351Spinal fusion surgeryFAERS: 3US FAERS
352StomatitisFAERS: 3US FAERS
353Suspected counterfeit productFAERS: 3US FAERS
354Temperature intoleranceFAERS: 3US FAERS
355Therapeutic response changedFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
356TinnitusFAERS: 3US FAERS
357UlcerFAERS: 3US FAERS
358Ventricular hypertrophyFAERS: 3US FAERS
359White blood cell count abnormalFAERS: 3US FAERS
360Wrong technique in drug usage processFAERS: 3US FAERS
361Abdominal hernia obstructiveFAERS: 2US FAERS
362AcidosisFAERS: 2OFFSIDES
US FAERS
363AgitationFAERS: 2US FAERS
364Amyotrophic Lateral SclerosisFAERS: 2US FAERS
365Anal UlcerFAERS: 2US FAERS
366AngerFAERS: 2US FAERS
367Antiphospholipid SyndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
368AnuriaFAERS: 2OFFSIDES
US FAERS
369Aortic AneurysmFAERS: 2US FAERS
370AphagiaFAERS: 2OFFSIDES
US FAERS
371AphoniaFAERS: 2US FAERS
372Aphthous StomatitisFAERS: 2US FAERS
373AppendicitisFAERS: 2US FAERS
374ArteriosclerosisFAERS: 2US FAERS
375Arteriovenous fistula thrombosisFAERS: 2US FAERS
376Aspartate Aminotransferase IncreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
377Atrioventricular Septal DefectFAERS: 2US FAERS
378Autoimmune thrombocytopeniaFAERS: 2OFFSIDES
US FAERS
379B-lymphocyte count decreasedFAERS: 2US FAERS
380Bile Duct StenosisFAERS: 2OFFSIDES
US FAERS
381Biliary anastomosis complicationFAERS: 2US FAERS
382Bladder tamponadeFAERS: 2US FAERS
383Blood alkaline phosphatase increasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
384Blood amylase increasedFAERS: 2US FAERS
385Blood potassium decreasedFAERS: 2US FAERS
386Bone marrow toxicityFAERS: 2US FAERS
387BrachydactylyFAERS: 2US FAERS
388Brain DeathFAERS: 2OFFSIDES
US FAERS
389BronchopneumoniaFAERS: 2OFFSIDES
US FAERS
390CD4 Lymphocytes DecreasedFAERS: 2US FAERS
391Calicivirus test positiveFAERS: 2US FAERS
392Carbon dioxide decreasedFAERS: 2US FAERS
393CholestasisFAERS: 2US FAERS
394Chronic graft versus host disease in skinFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
395Congenital diaphragmatic herniaFAERS: 2US FAERS
396Craniofacial DysostosisFAERS: 2US FAERS
397CraniosynostosisFAERS: 2US FAERS
398Creatinine renal clearance decreasedFAERS: 2OFFSIDES
US FAERS
399Cytomegalovirus chorioretinitisFAERS: 2US FAERS
400Delayed Graft FunctionFAERS: 2US FAERS
401DemyelinationFAERS: 2OFFSIDES
US FAERS
402Depressed Level of ConsciousnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
403Depressed moodFAERS: 2US FAERS
404Device related infectionFAERS: 2US FAERS
405DiplopiaFAERS: 2US FAERS
406Dissociative disorderFAERS: 2US FAERS
407Drug level below therapeuticFAERS: 2OFFSIDES
US FAERS
408DysmorphismFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
409EmbolismFAERS: 2US FAERS
410Emotional disorderFAERS: 2US FAERS
411Eosinophilic granulomatosis with polyangiitisFAERS: 2US FAERS
412Epstein-Barr virus test positiveFAERS: 2US FAERS
413Extremity necrosisFAERS: 2US FAERS
414Eye inflammationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
415Eye painFAERS: 2US FAERS
416Facial paralysisFAERS: 2US FAERS
417Feeling ColdFAERS: 2US FAERS
418FibromyalgiaFAERS: 2US FAERS
419Fluid overloadFAERS: 2OFFSIDES
US FAERS
420Gastric BypassFAERS: 2US FAERS
421Gastrointestinal mucosal disorderFAERS: 2US FAERS
422Gastrointestinal perforationFAERS: 2US FAERS
423GastrostomyFAERS: 2US FAERS
424Gaze palsyFAERS: 2US FAERS
425Genital painFAERS: 2US FAERS
426Gingival RecessionFAERS: 2US FAERS
427GingivitisFAERS: 2US FAERS
428Graft versus host disease in eyeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
429HemiparesisFAERS: 2OFFSIDES
US FAERS
430Hepatitis BFAERS: 2OFFSIDES
US FAERS
431HepatosplenomegalyFAERS: 2US FAERS
432HistoplasmosisFAERS: 2US FAERS
433HydronephrosisFAERS: 2US FAERS
434HyperaldosteronismFAERS: 2US FAERS
435Hypertensive emergencyFAERS: 2US FAERS
436HypoxiaFAERS: 2US FAERS
437ImmobileFAERS: 2US FAERS
438IncontinenceFAERS: 2US FAERS
439Increased tendency to bruiseFAERS: 2US FAERS
440Infusion Site ExtravasationFAERS: 2US FAERS
441Intentional drug misuseFAERS: 2US FAERS
442Intentional product misuseFAERS: 2US FAERS
443Intestinal infarctionFAERS: 2US FAERS
444Irritable Bowel SyndromeFAERS: 2US FAERS
445Mastication disorderFAERS: 2US FAERS
446Metabolic acidosisFAERS: 2US FAERS
447MicrophthalmosFAERS: 2US FAERS
448Multifocal motor neuropathyFAERS: 2US FAERS
449Muscle CrampFAERS: 2US FAERS
450Muscle strainFAERS: 2US FAERS
451Muscle tightnessFAERS: 2US FAERS
452Musculoskeletal PainFAERS: 2US FAERS
453Musculoskeletal stiffnessFAERS: 2OFFSIDES
US FAERS
454MyositisFAERS: 2US FAERS
455NephrectomyFAERS: 2US FAERS
456ObesityFAERS: 2US FAERS
457Occult blood positiveFAERS: 2US FAERS
458Occupational exposure to productFAERS: 2US FAERS
459OsteoporosisFAERS: 2OFFSIDES
US FAERS
460OverweightFAERS: 2US FAERS
461ParanoiaFAERS: 2US FAERS
462ParaplegiaFAERS: 2US FAERS
463ParathyroidectomyFAERS: 2US FAERS
464PetechiaeFAERS: 2US FAERS
465Pneumatosis intestinalisFAERS: 2US FAERS
466PneumothoraxFAERS: 2US FAERS
467Poor peripheral circulationFAERS: 2US FAERS
468Poor quality sleepFAERS: 2US FAERS
469Pressure of speechFAERS: 2US FAERS
470Product counterfeitFAERS: 2US FAERS
471Product use complaintFAERS: 2US FAERS
472Protein total increasedFAERS: 2US FAERS
473Pruritus allergicFAERS: 2OFFSIDES
US FAERS
474PsoriasisFAERS: 2US FAERS
475Pulmonary HypertensionFAERS: 2OFFSIDES
US FAERS
476Pulmonary InfarctionFAERS: 2US FAERS
477Quality of life decreasedFAERS: 2OFFSIDES
US FAERS
478Rectal dischargeFAERS: 2US FAERS
479Renal Artery StenosisFAERS: 2US FAERS
480RetchingFAERS: 2US FAERS
481Retinal DetachmentFAERS: 2US FAERS
482Rheumatoid factor increasedFAERS: 2US FAERS
483ScabFAERS: 2US FAERS
484ScleritisFAERS: 2US FAERS
485SclerodactyliaFAERS: 2US FAERS
486Single umbilical arteryFAERS: 2US FAERS
487Sjogren's SyndromeFAERS: 2US FAERS
488Stevens-Johnson SyndromeFAERS: 2US FAERS
489Sudden Cardiac DeathFAERS: 2US FAERS
490Suture related complicationFAERS: 2US FAERS
491SynovitisFAERS: 2US FAERS
492Systemic Inflammatory Response SyndromeFAERS: 2US FAERS
493Systemic SclerodermaFAERS: 2US FAERS
494Terminal stateFAERS: 2US FAERS
495Thermal burnFAERS: 2US FAERS
496Tooth ExtractionFAERS: 2US FAERS
497TrichorrhexisFAERS: 2US FAERS
498TuberculosisFAERS: 2US FAERS
499Varicella Zoster Virus InfectionFAERS: 2US FAERS
500Ventricular FibrillationFAERS: 2US FAERS
501VertebroplastyFAERS: 2US FAERS
502Visual disturbanceFAERS: 2US FAERS
503WheezingFAERS: 2US FAERS
504effusionFAERS: 2US FAERS
505intensive careFAERS: 2US FAERS
506Abdominal adhesionsFAERS: 1US FAERS
507Abdominal massFAERS: 1US FAERS
508Abdominal tendernessFAERS: 1US FAERS
509AbuliaFAERS: 1US FAERS
510Accidental exposureFAERS: 1US FAERS
511Acid fast bacilli infectionFAERS: 1US FAERS
512Acquired porphyriaFAERS: 1US FAERS
513Acute Coronary SyndromeFAERS: 1US FAERS
514AdenocarcinomaFAERS: 1US FAERS
515Adenoviral hepatitisFAERS: 1US FAERS
516Allergic sinusitisFAERS: 1US FAERS
517Alopecia AreataFAERS: 1US FAERS
518Alopecia totalisFAERS: 1US FAERS
519Altered state of consciousnessFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
520Altered visual depth perceptionFAERS: 1US FAERS
521AmblyopiaFAERS: 1US FAERS
522AmputationFAERS: 1US FAERS
523Anal abscessFAERS: 1US FAERS
524Anal squamous cell carcinomaFAERS: 1US FAERS
525Anaphylactic shockFAERS: 1US FAERS
526Angina PectorisFAERS: 1US FAERS
527Angular cheilitisFAERS: 1US FAERS
528Animal biteFAERS: 1US FAERS
529AnorexiaFAERS: 1US FAERS
530Antibody test negativeFAERS: 1US FAERS
531Aortic RuptureFAERS: 1US FAERS
532Apallic syndromeFAERS: 1US FAERS
533ApathyFAERS: 1US FAERS
534Arterial InjuryFAERS: 1US FAERS
535Arterial therapeutic procedureFAERS: 1US FAERS
536AsphyxiaFAERS: 1US FAERS
537AsterixisFAERS: 1US FAERS
538AstrocytomaFAERS: 1US FAERS
539Astrovirus test positiveFAERS: 1US FAERS
540Autonomic neuropathyFAERS: 1US FAERS
541BankruptcyFAERS: 1US FAERS
542Benign Prostatic HyperplasiaFAERS: 1US FAERS
543Biliary ColicFAERS: 1US FAERS
544Biliary FistulaFAERS: 1US FAERS
545Biliary abscessFAERS: 1US FAERS
546Bladder NeoplasmFAERS: 1US FAERS
547Bladder prolapseFAERS: 1US FAERS
548BlepharospasmFAERS: 1US FAERS
549Blood bilirubin abnormalFAERS: 1US FAERS
550Blood cholesterol increasedFAERS: 1US FAERS
551Blood creatine increasedFAERS: 1US FAERS
552Blood immunoglobulin G decreasedFAERS: 1US FAERS
553Blood magnesium decreasedFAERS: 1US FAERS
554Blood parathyroid hormone increasedFAERS: 1US FAERS
555Blood pressure fluctuationFAERS: 1US FAERS
556Blood urea nitrogen/creatinine ratio decreasedFAERS: 1US FAERS
557Blood urine presentFAERS: 1US FAERS
558Body height below normalFAERS: 1US FAERS
559Bone density decreasedFAERS: 1OFFSIDES
US FAERS
560Bowen's DiseaseFAERS: 1US FAERS
561BradyphreniaFAERS: 1US FAERS
562Brain AbscessFAERS: 1OFFSIDES
US FAERS
563BronchospasmFAERS: 1US FAERS
564Butterfly rashFAERS: 1US FAERS
565CachexiaFAERS: 1US FAERS
566Cardiac TamponadeFAERS: 1US FAERS
567Cardiac sarcoidosisFAERS: 1US FAERS
568Cardiac valve vegetationFAERS: 1US FAERS
569CardiotoxicityFAERS: 1US FAERS
570Carotid artery occlusionFAERS: 1US FAERS
571Cavernous Sinus ThrombosisFAERS: 1US FAERS
572Cerebellar AtaxiaFAERS: 1OFFSIDES
US FAERS
573Cerebellar dysplasiaFAERS: 1US FAERS
574Cerebral atrophyFAERS: 1US FAERS
575Cervical dysplasiaFAERS: 1US FAERS
576Cervix carcinomaFAERS: 1US FAERS
577CheilitisFAERS: 1US FAERS
578ChorioamnionitisFAERS: 1US FAERS
579ChorioretinitisFAERS: 1US FAERS
580Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroidsFAERS: 1US FAERS
581Cleft uvulaFAERS: 1US FAERS
582Clostridium difficile colitisFAERS: 1US FAERS
583ClubbingFAERS: 1US FAERS
584ClumsinessFAERS: 1US FAERS
585Coagulation factor VII level decreasedFAERS: 1US FAERS
586Colonic fistulaFAERS: 1US FAERS
587Complication associated with deviceFAERS: 1US FAERS
588Complications of intestinal transplantFAERS: 1US FAERS
589Congenital acrochordonFAERS: 1US FAERS
590Congenital anomaly in offspringFAERS: 1US FAERS
591Congenital hearing disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
592Congenital hydronephrosisFAERS: 1US FAERS
593Congenital osteodystrophyFAERS: 1US FAERS
594Congenital renal cystFAERS: 1US FAERS
595ConjunctivitisFAERS: 1US FAERS
596Cor pulmonaleFAERS: 1US FAERS
597Corneal PerforationFAERS: 1OFFSIDES
US FAERS
598Corneal thinningFAERS: 1US FAERS
599Craniofacial deformityFAERS: 1US FAERS
600Crushing injury of trunkFAERS: 1US FAERS
601Cystic FibrosisFAERS: 1US FAERS
602Cytolytic hepatitisFAERS: 1US FAERS
603Cytomegalovirus testFAERS: 1US FAERS
604Deafness NeurosensoryFAERS: 1US FAERS
605Decreased immune responsivenessFAERS: 1US FAERS
606Dengue FeverFAERS: 1US FAERS
607Dental cariesFAERS: 1OFFSIDES
US FAERS
608Dermatitis acneiformFAERS: 1US FAERS
609DermatitisFAERS: 1US FAERS
610Device FailureFAERS: 1OFFSIDES
US FAERS
611Device dislocationFAERS: 1US FAERS
612Device dispensing errorFAERS: 1US FAERS
613Device occlusionFAERS: 1US FAERS
614Diabetes mellitus inadequate controlFAERS: 1OFFSIDES
US FAERS
615Diabetes with hyperosmolarityFAERS: 1US FAERS
616Diabetic FootFAERS: 1US FAERS
617Diabetic KetoacidosisFAERS: 1US FAERS
618Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
619Diffuse alopeciaFAERS: 1US FAERS
620Diffuse large B-cell lymphoma recurrentFAERS: 1US FAERS
621DiplegiaFAERS: 1US FAERS
622DisabilityFAERS: 1US FAERS
623DiscomfortFAERS: 1US FAERS
624Disease complicationFAERS: 1US FAERS
625DisorientationFAERS: 1US FAERS
626Diverticular perforationFAERS: 1US FAERS
627DiverticulumFAERS: 1US FAERS
628Drug ToleranceFAERS: 1US FAERS
629Drug resistanceFAERS: 1US FAERS
630Drug screen negativeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
631Drug titration errorFAERS: 1US FAERS
632Drug toxicityFAERS: 1OFFSIDES
US FAERS
633Duodenal atresiaFAERS: 1US FAERS
634Duodenal perforationFAERS: 1US FAERS
635DysgraphiaFAERS: 1US FAERS
636Ectopic kidneyFAERS: 1US FAERS
637Ejection Fraction DecreasedFAERS: 1US FAERS
638EmpyemaFAERS: 1US FAERS
639EndophthalmitisFAERS: 1US FAERS
640Enterobacter pneumoniaFAERS: 1US FAERS
641Enterococcal infectionFAERS: 1OFFSIDES
US FAERS
642EnterocolitisFAERS: 1US FAERS
643Eosinophilic colitisFAERS: 1US FAERS
644Erythema MultiformeFAERS: 1US FAERS
645Escherichia infectionFAERS: 1OFFSIDES
US FAERS
646Escherichia sepsisFAERS: 1US FAERS
647Essential HypertensionFAERS: 1US FAERS
648Evans syndromeFAERS: 1US FAERS
649ExophthalmosFAERS: 1US FAERS
650Eye InfectionFAERS: 1US FAERS
651Facial PainFAERS: 1US FAERS
652Factor XII DeficiencyFAERS: 1US FAERS
653FibrosisFAERS: 1US FAERS
654Focal glomerulosclerosisFAERS: 1OFFSIDES
US FAERS
655Food PoisoningFAERS: 1US FAERS
656FormicationFAERS: 1US FAERS
657Full blood count increasedFAERS: 1US FAERS
658Gastritis herpesFAERS: 1US FAERS
659Gastrointestinal candidiasisFAERS: 1US FAERS
660Gastrointestinal carcinomaFAERS: 1US FAERS
661Gastrointestinal erosionFAERS: 1US FAERS
662Gastrointestinal hypomotilityFAERS: 1US FAERS
663Gastrointestinal inflammationFAERS: 1US FAERS
664Gastrointestinal motility disorderFAERS: 1US FAERS
665Gastrointestinal obstructionFAERS: 1US FAERS
666Gastrointestinal protozoal infectionFAERS: 1US FAERS
667Gastrointestinal sounds abnormalFAERS: 1US FAERS
668Gastrointestinal ulcerFAERS: 1US FAERS
669Gene MutationFAERS: 1US FAERS
670Gingival HyperplasiaFAERS: 1US FAERS
671Gingival HypertrophyFAERS: 1US FAERS
672GlioblastomaFAERS: 1US FAERS
673Graft dysfunctionFAERS: 1US FAERS
674Graft lossFAERS: 1US FAERS
675Graft versus host disease in intestineFAERS: 1US FAERS
676Granulocyte count decreasedFAERS: 1US FAERS
677Grip strength decreasedFAERS: 1US FAERS
678Growth retardationFAERS: 1US FAERS
679Heart alternationFAERS: 1US FAERS
680Hepatitis C RNA increasedFAERS: 1US FAERS
681Hepatorenal SyndromeFAERS: 1US FAERS
682Hilar lymphadenopathyFAERS: 1US FAERS
683Hip surgeryFAERS: 1US FAERS
684HoloprosencephalyFAERS: 1US FAERS
685Hospice CareFAERS: 1US FAERS
686HungerFAERS: 1US FAERS
687HypersomniaFAERS: 1US FAERS
688HypertrichosisFAERS: 1US FAERS
689HypogonadismFAERS: 1US FAERS
690HypokinesiaFAERS: 1US FAERS
691Hypoplastic Left Heart SyndromeFAERS: 1US FAERS
692HyporeflexiaFAERS: 1OFFSIDES
US FAERS
693HypothyroidismFAERS: 1US FAERS
694IleitisFAERS: 1US FAERS
695Illogical thinkingFAERS: 1US FAERS
696Immune Reconstitution Inflammatory SyndromeFAERS: 1US FAERS
697Immunosuppressant drug level increasedFAERS: 1US FAERS
698Impaired work abilityFAERS: 1US FAERS
699ImpetigoFAERS: 1US FAERS
700Implant tissue necrosisFAERS: 1US FAERS
701Inability to afford medicationFAERS: 1US FAERS
702Inappropriate schedule of product administrationFAERS: 1US FAERS
703Incorrect drug administration durationFAERS: 1US FAERS
704Incorrect drug administration rateFAERS: 1US FAERS
705Incorrect drug dosage form administeredFAERS: 1US FAERS
706Incorrect route of drug administrationFAERS: 1US FAERS
707InfarctionFAERS: 1US FAERS
708Infusion site painFAERS: 1US FAERS
709Initial insomniaFAERS: 1US FAERS
710Injection site dischargeFAERS: 1US FAERS
711Injection site ulcerFAERS: 1US FAERS
712Intermittent ClaudicationFAERS: 1US FAERS
713Intestinal resectionFAERS: 1US FAERS
714Intracranial massFAERS: 1US FAERS
715Intraspinal abscessFAERS: 1US FAERS
716IridocyclitisFAERS: 1US FAERS
717JC virus test positiveFAERS: 1US FAERS
718Joint Range of Motion DecreasedFAERS: 1OFFSIDES
US FAERS
719Joint injuryFAERS: 1US FAERS
720KeratitisFAERS: 1US FAERS
721LaryngomalaciaFAERS: 1US FAERS
722LazinessFAERS: 1US FAERS
723Lichen PlanusFAERS: 1US FAERS
724Limb reconstructive surgeryFAERS: 1US FAERS
725Lipids abnormalFAERS: 1US FAERS
726LipomaFAERS: 1US FAERS
727Loss of personal independence in daily activitiesFAERS: 1US FAERS
728Low density lipoprotein increasedFAERS: 1US FAERS
729Low set earsFAERS: 1US FAERS
730Lung cystFAERS: 1US FAERS
731Lung squamous cell carcinoma stage IVFAERS: 1US FAERS
732Lupus enteritisFAERS: 1US FAERS
733Lyme DiseaseFAERS: 1US FAERS
734Lymphocyte count increasedFAERS: 1US FAERS
735LymphocytosisFAERS: 1US FAERS
736Malignant neoplasm progressionFAERS: 1US FAERS
737Malignant tumour excisionFAERS: 1US FAERS
738Mandibulofacial DysostosisFAERS: 1US FAERS
739MeningoceleFAERS: 1US FAERS
740Meniscus injuryFAERS: 1US FAERS
741MenorrhagiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
742MetamorphopsiaFAERS: 1US FAERS
743Metastases to muscleFAERS: 1US FAERS
744MicrocephalyFAERS: 1US FAERS
745MicrogeniaFAERS: 1US FAERS
746Migraine with AuraFAERS: 1US FAERS
747Monocyte count decreasedFAERS: 1US FAERS
748Multi-organ disorderFAERS: 1OFFSIDES
US FAERS
749Myasthenic SyndromeFAERS: 1US FAERS
750Nasal FlaringFAERS: 1US FAERS
751Neonatal pneumoniaFAERS: 1US FAERS
752Nephritic syndromeFAERS: 1US FAERS
753Nerve BlockFAERS: 1US FAERS
754NervousnessFAERS: 1US FAERS
755NeuralgiaFAERS: 1OFFSIDES
US FAERS
756Neuromyelitis OpticaFAERS: 1US FAERS
757Neutropenic sepsisFAERS: 1US FAERS
758No adverse effectFAERS: 1US FAERS
759NoduleFAERS: 1US FAERS
760OnychoclasisFAERS: 1US FAERS
761OnychomycosisFAERS: 1US FAERS
762Optic NeuropathyFAERS: 1US FAERS
763Oral candidiasisFAERS: 1US FAERS
764Oral painFAERS: 1US FAERS
765OrchitisFAERS: 1US FAERS
766OsteomyelitisFAERS: 1OFFSIDES
US FAERS
767Pain of skinFAERS: 1OFFSIDES
US FAERS
768PallorFAERS: 1US FAERS
769Pancreatic operationFAERS: 1US FAERS
770Panic DisorderFAERS: 1US FAERS
771PanniculitisFAERS: 1US FAERS
772Paratracheal lymphadenopathyFAERS: 1US FAERS
773Paternal exposure before pregnancyFAERS: 1US FAERS
774Pelvic Inflammatory DiseaseFAERS: 1US FAERS
775Personality ChangeFAERS: 1US FAERS
776Pharmaceutical product complaintFAERS: 1US FAERS
777PharyngitisFAERS: 1US FAERS
778Pharyngolaryngeal PainFAERS: 1US FAERS
779Pierre Robin SyndromeFAERS: 1US FAERS
780PlasmapheresisFAERS: 1US FAERS
781Platelet count abnormalFAERS: 1US FAERS
782PolymyositisFAERS: 1OFFSIDES
US FAERS
783Polyomavirus-associated nephropathyFAERS: 1OFFSIDES
US FAERS
784Portal HypertensionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
785Post procedural complicationFAERS: 1US FAERS
786Post procedural swellingFAERS: 1US FAERS
787Postrenal failureFAERS: 1US FAERS
788Prader-Willi SyndromeFAERS: 1US FAERS
789Pre-EclampsiaFAERS: 1US FAERS
790Prescribed overdoseFAERS: 1US FAERS
791Product appearance confusionFAERS: 1US FAERS
792Product availability issueFAERS: 1US FAERS
793Product closure issueFAERS: 1US FAERS
794Product coating issueFAERS: 1US FAERS
795Product contaminationFAERS: 1US FAERS
796Product dispensing issueFAERS: 1US FAERS
797Product distribution issueFAERS: 1US FAERS
798Product gel formationFAERS: 1US FAERS
799Product prescribing errorFAERS: 1US FAERS
800Product size issueFAERS: 1US FAERS
801Product storage errorFAERS: 1US FAERS
802Prostatic specific antigen decreasedFAERS: 1US FAERS
803Protein-losing gastroenteropathyFAERS: 1US FAERS
804Pseudomonal sepsisFAERS: 1US FAERS
805Pseudomonas bronchitisFAERS: 1US FAERS
806Psychiatric evaluationFAERS: 1US FAERS
807PterygiumFAERS: 1US FAERS
808Pulmonary thrombosisFAERS: 1US FAERS
809Pulmonary toxicityFAERS: 1US FAERS
810Purpura FulminansFAERS: 1US FAERS
811PurpuraFAERS: 1US FAERS
812Purulent dischargeFAERS: 1US FAERS
813PyelonephritisFAERS: 1OFFSIDES
US FAERS
814Pyloric StenosisFAERS: 1US FAERS
815Pyoderma GangrenosumFAERS: 1US FAERS
816PyuriaFAERS: 1US FAERS
817QuadriplegiaFAERS: 1OFFSIDES
US FAERS
818Reaction to drug excipientsFAERS: 1US FAERS
819Rectal ProlapseFAERS: 1US FAERS
820RegurgitationFAERS: 1US FAERS
821Renal tubular acidosisFAERS: 1US FAERS
822Reperfusion InjuryFAERS: 1US FAERS
823Residual urineFAERS: 1US FAERS
824Respiratory papillomaFAERS: 1US FAERS
825RestlessnessFAERS: 1US FAERS
826Retinal DegenerationFAERS: 1US FAERS
827RetinitisFAERS: 1US FAERS
828RetrognathiaFAERS: 1US FAERS
829Rhinitis perennialFAERS: 1US FAERS
830Ruptured cerebral aneurysmFAERS: 1US FAERS
831Salmonella test positiveFAERS: 1US FAERS
832SarcoidosisFAERS: 1US FAERS
833Sclerosing encapsulating peritonitisFAERS: 1US FAERS
834Senile dementiaFAERS: 1US FAERS
835Septic embolusFAERS: 1US FAERS
836Shoulder deformityFAERS: 1US FAERS
837Skeletal injuryFAERS: 1US FAERS
838Skin irritationFAERS: 1US FAERS
839SluggishnessFAERS: 1US FAERS
840SmallpoxFAERS: 1US FAERS
841Spinal column stenosisFAERS: 1US FAERS
842Splenic neoplasm malignancy unspecifiedFAERS: 1US FAERS
843SplenomegalyFAERS: 1US FAERS
844SplinterFAERS: 1US FAERS
845Squamous cell carcinoma of lungFAERS: 1US FAERS
846StillbirthFAERS: 1US FAERS
847StrongyloidiasisFAERS: 1US FAERS
848Subacute endocarditisFAERS: 1US FAERS
849Sudden deathFAERS: 1US FAERS
850Superinfection lungFAERS: 1US FAERS
851Supraventricular tachycardiaFAERS: 1US FAERS
852Synovial CystFAERS: 1US FAERS
853T-Cell LymphomaFAERS: 1US FAERS
854TachyarrhythmiaFAERS: 1US FAERS
855TalipesFAERS: 1US FAERS
856Tension HeadacheFAERS: 1US FAERS
857Therapeutic product effect variableFAERS: 1US FAERS
858Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
859Therapeutic response unexpectedFAERS: 1US FAERS
860Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
861Therapy regimen changedFAERS: 1US FAERS
862ThirstFAERS: 1US FAERS
863ThrombocytosisFAERS: 1US FAERS
864Tinea PedisFAERS: 1US FAERS
865Tongue bitingFAERS: 1US FAERS
866Tooth LossFAERS: 1US FAERS
867Toxic Epidermal NecrolysisFAERS: 1US FAERS
868Toxic Shock SyndromeFAERS: 1US FAERS
869Tracheal StenosisFAERS: 1US FAERS
870Transaminases abnormalFAERS: 1US FAERS
871Transitional cell carcinoma metastaticFAERS: 1US FAERS
872Tuberculoma of central nervous systemFAERS: 1US FAERS
873Tumour haemorrhageFAERS: 1US FAERS
874Unresponsive to stimuliFAERS: 1US FAERS
875Upper respiratory fungal infectionFAERS: 1US FAERS
876Upper respiratory tract inflammationFAERS: 1US FAERS
877Upper-airway cough syndromeFAERS: 1US FAERS
878Urinary RetentionFAERS: 1US FAERS
879Urinary bladder atrophyFAERS: 1US FAERS
880Urinary tract infection viralFAERS: 1US FAERS
881Urinary tract obstructionFAERS: 1US FAERS
882Urine protein/creatinine ratio abnormalFAERS: 1US FAERS
883Uterine CancerFAERS: 1US FAERS
884Uterine ProlapseFAERS: 1US FAERS
885UveitisFAERS: 1US FAERS
886VIIth nerve paralysisFAERS: 1US FAERS
887Vagus Nerve DisorderFAERS: 1US FAERS
888Vascular compressionFAERS: 1US FAERS
889Viral vasculitisFAERS: 1US FAERS
890Vitamin D DeficiencyFAERS: 1US FAERS
891Walking aid userFAERS: 1US FAERS
892West Nile viral infectionFAERS: 1US FAERS
893Withdrawal of life supportFAERS: 1US FAERS
894Wrong doseFAERS: 1US FAERS
895hypertensive nephropathyFAERS: 1US FAERS
896insulinomaFAERS: 1US FAERS
897pseudomembranous colitisFAERS: 1US FAERS
898Abdominal AbscessOFFSIDES
899Acute bronchitisOFFSIDES
900Acute graft versus host disease in intestineOFFSIDES
901AdenitisOFFSIDES
902AlveolitisOFFSIDES
903AnhedoniaOFFSIDES
904Anti-platelet antibody positiveOFFSIDES
905AspergillosisOFFSIDES
906Bacteria sputum identifiedOFFSIDES
907Bacterial culture positiveOFFSIDES
908Bacterial pyelonephritisCanada Vigilance: 1Canada Vigilance
909Biliary sphincterotomyOFFSIDES
910Bipolar DisorderOFFSIDES
911Blood chloride increasedOFFSIDES
912Blood creatine phosphokinase decreasedOFFSIDES
913Blood lactate dehydrogenase increasedCanada Vigilance: 1Canada Vigilance
914Blood potassiumOFFSIDES
915Blood product transfusion dependentOFFSIDES
916Blood sodium decreasedCanada Vigilance: 1Canada Vigilance
917Bone infarctionOFFSIDES
918Bone lesionOFFSIDES
919Breast necrosisOFFSIDES
920CYTOMEGALOVIRUS ANTIGENOFFSIDES
921Cardiac FlutterOFFSIDES
922Chemotherapeutic drug level increasedOFFSIDES
923Chronic left ventricular failureOFFSIDES
924Congenital intestinal malformationCanada Vigilance: 2Canada Vigilance
925Cutaneous CandidiasisOFFSIDES
926Cytomegalovirus antibody positiveOFFSIDES
927DebridementOFFSIDES
928DiabetesOFFSIDES
929Diabetes InsipidusOFFSIDES
930DiverticulosisOFFSIDES
931Endoscopy abnormalOFFSIDES
932Engraftment syndromeOFFSIDES
933ErythropeniaOFFSIDES
934ExcoriationOFFSIDES
935Exfoliative rashOFFSIDES
936Extremity contractureOFFSIDES
937Eye allergyOFFSIDES
938Fatty LiverOFFSIDES
939Fungus serology test positiveOFFSIDES
940Gait inabilityCanada Vigilance: 1Canada Vigilance
941Gamma-Glutamyltransferase IncreasedOFFSIDES
942Graft infectionOFFSIDES
943Graft versus host disease in liverCanada Vigilance: 1Canada Vigilance
944Graft versus host disease in lungCanada Vigilance: 1Canada Vigilance
945Graft versus host disease in skinCanada Vigilance: 1Canada Vigilance
946Grip strengthOFFSIDES
947HLA marker studyOFFSIDES
948HaematotoxicityOFFSIDES
949Hepatic artery stenosisOFFSIDES
950Hepatic artery thrombosisOFFSIDES
951Hepatitis B positiveOFFSIDES
952Hepatitis C antibody positiveOFFSIDES
953Human herpesvirus 8 infectionOFFSIDES
954HydrophobiaOFFSIDES
955HyperpigmentationOFFSIDES
956Immunosuppressant drug levelOFFSIDES
957Infusion site mobility decreasedOFFSIDES
958Intestinal malrotation repairCanada Vigilance: 1Canada Vigilance
959IntussusceptionOFFSIDES
960Joint InstabilityOFFSIDES
961Joint stiffnessOFFSIDES
962Klebsiella sepsisOFFSIDES
963Leukopenia neonatalOFFSIDES
964Lung consolidationOFFSIDES
965Lupus pneumonitisOFFSIDES
966LymphoceleOFFSIDES
967MarasmusOFFSIDES
968Maternal exposure before pregnancyCanada Vigilance: 1Canada Vigilance
969Mechanical ventilationOFFSIDES
970Mitochondrial myopathy acquiredOFFSIDES
971MucormycosisOFFSIDES
972Muscle FatigueOFFSIDES
973Muscle WeaknessOFFSIDES
974Muscle flap operationOFFSIDES
975Muscle necrosisOFFSIDES
976Myoglobin blood presentOFFSIDES
977Nephrogenic Fibrosing DermopathyOFFSIDES
978OliguriaOFFSIDES
979OphthalmoplegiaOFFSIDES
980Oropharyngitis fungalOFFSIDES
981OsteolysisOFFSIDES
982OsteomaOFFSIDES
983OsteoradionecrosisOFFSIDES
984Ovarian failureOFFSIDES
985Pancreatic CystOFFSIDES
986Pericarditis lupusOFFSIDES
987PeriodontitisOFFSIDES
988Poor personal hygieneOFFSIDES
989Post procedural bile leakOFFSIDES
990Posterior CapsulotomyOFFSIDES
991Potentiating drug interactionOFFSIDES
992Precocious PubertyOFFSIDES
993Primary sequestrumOFFSIDES
994Pulmonary vascular disorderOFFSIDES
995Renal tubular atrophyOFFSIDES
996Renal tubular disorderOFFSIDES
997Retinal VasculitisOFFSIDES
998SequestrectomyOFFSIDES
999Skin IndurationOFFSIDES
1000Skin tightnessOFFSIDES
1001Stem cell transplantOFFSIDES
1002Subcutaneous noduleOFFSIDES
1003Systemic mycosisOFFSIDES
1004TineaOFFSIDES
1005TonsillitisCanada Vigilance: 1Canada Vigilance
1006Tooth InfectionOFFSIDES
1007Urinary tract infection pseudomonalOFFSIDES
1008Venoocclusive diseaseOFFSIDES
1009Weight GainOFFSIDES
1010Wound InfectionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.